Comparison of Ion Trap and Q-TOF Mass Spectrometers for Protein Identification
October 2nd 2009This study uses the challenging analysis of a complex, multi-organ peptide digest of Caenorhabditis elegans (C. elegans) to compare the performance of a novel linear ion trap mass spectrometer and a quadrupole time-of-flight (Q-TOF) mass spectrometer.
Fast Separation of Seven Biocides Using an Agilent ZORBAX RRHD Eclipse Plus C18 1.8 µm Column
October 2nd 2009The flexibility to use short sub-2 micron columns on UHPLC instruments at high flow-rates permits fast analysis with high resolution of complex samples. An Agilent ZORBAX Rapid Resolution High Definition (RRHD) Eclipse Plus C18 1.8 µm column separated seven different biocides in less than 1 minute with high resolution. A flow-rate of 1.7 mL/min was used on 2.1 × 50 mm column to achieve the rapid separation. The Agilent 1290 Infinity LC system was used as the column pressure just exceeded 1000 bar at this high flow-rate. A sample of hand sanitizer was found to contain 2-phenoxyethanol and methylparaben using the method.
The Third Annual LCGC Pittcon Awards: Establishing a Tradition
October 1st 2009They say it takes several years for an awards program to really get off the ground and start amassing a history, establishing a place for itself in the industry. If this is true, then I believe we can safely say that this year, the LCGC Pittcon Awards have officially arrived. With past Lifetime Achievement Award winners such as Walt Jennings and Harold McNair, and bright young stars such as Gert Desmet and Kevin Schug claiming Emerging Leader honors over the past couple of years, there is a great deal of suspense building over who will win the 2010 awards, set to be presented at Pittcon 2010 in Orlando, Florida.
Advanced Profiling Method based on MELDI–MS For High-Throughput Pattern Analysis in Proteomics
October 1st 2009A new proteomic profiling method based on material-enhanced laser desorption/ionization (MELDI) has been developed to identify candidate biomarkers that are selected in MELDI mass profiles. The basic principle of applying MELDI is to trace out the low-concentration species generated as a result of disease, which can then be used as diagnostic markers after their authentic validation. The first step of the MELDI approach is applied to reduce the complexity of proteomic samples by specific binding of serum proteins onto chemically modified MELDI beads, which are then directly analysed by matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) mass spectrometry (MS). The resulting mass profiles provide the basis for differentiating diseased samples from control samples. The use of liquid handling robots for sample preparation for high-throughput applications leads to higher reproducibility, which is crucial to succesfully identify disease markers. The ongoing development of MELDI for the..
The Column: September 2009 Issue 2
September 24th 2009Advancements to Take the Pain Out of Chromatographic Peak Integration Shaun Quinn Reducing Time and Cost with Multi-vendor Chromatographic System Control Mark Harnois, Chris Stumpf and Steven F. Eaton Meeting Review: SFC 2009 - 3rd International Conference on Packed Column Supercritical Fluid Chromatography Larry T. Taylor News Market Trends and Analysis Market Profile: Worldwide Ion Chromatography Demand Glenn Cudiamat Events